Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Current Oncology (Toronto, Ont.)
|
December 31, 2020
Presenting stage and risk group in men dying of prostate cancer
S Parimi, S Bondy, M Aparicio, et al.
Australasian Radiology
|
December 31, 1997
Percutaneous gastrostomy in radiologic practice
P L Munk, M J Lee, P Y Poon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 8, 2010
Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies
C Kollmannsberger, S Tyldesley, C Moore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2015
Population-based analysis of the impact and generalizability of the NSABP-B24 study on endocrine therapy for patients with ductal carcinoma in situ of the breast
A C Lo, P T Truong, E S Wai, et al.
Breast (Edinburgh, Scotland)
|
March 20, 2012
A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapy
A Fong, J Shafiq, C Saunders, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 3, 2026
Development of Radiomics Models to Predict Progression-Free Survival and Early Polymetastatic Progression in Patients With Lung Oligometastases Treated on the Single-Arm Phase II Stereotactic Ablative Radiotherapy-5 Trial
T Kunkyab, D Hyde, B Mou, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 27, 2022
Validation of the Prognostic Utility of ESTRO/EORTC Oligometastatic Disease Classification: A Secondary Analysis From the Population-Based Phase II SABR-5 Trial
S Baker, B Mou, W Jiang, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 31, 2024
Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the Population-Based SABR-5 Phase II Trial
E M Cruz-Lim, B Mou, W Jiang, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
December 13, 2023
Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II Trial
E M Cruz-Lim, B Mou, S Baker, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Current Oncology (Toronto, Ont.)
|
December 31, 2020
Presenting stage and risk group in men dying of prostate cancer
S Parimi, S Bondy, M Aparicio, et al.
Australasian Radiology
|
December 31, 1997
Percutaneous gastrostomy in radiologic practice
P L Munk, M J Lee, P Y Poon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 8, 2010
Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies
C Kollmannsberger, S Tyldesley, C Moore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2015
Population-based analysis of the impact and generalizability of the NSABP-B24 study on endocrine therapy for patients with ductal carcinoma in situ of the breast
A C Lo, P T Truong, E S Wai, et al.
Breast (Edinburgh, Scotland)
|
March 20, 2012
A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapy
A Fong, J Shafiq, C Saunders, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 3, 2026
Development of Radiomics Models to Predict Progression-Free Survival and Early Polymetastatic Progression in Patients With Lung Oligometastases Treated on the Single-Arm Phase II Stereotactic Ablative Radiotherapy-5 Trial
T Kunkyab, D Hyde, B Mou, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 27, 2022
Validation of the Prognostic Utility of ESTRO/EORTC Oligometastatic Disease Classification: A Secondary Analysis From the Population-Based Phase II SABR-5 Trial
S Baker, B Mou, W Jiang, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 31, 2024
Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the Population-Based SABR-5 Phase II Trial
E M Cruz-Lim, B Mou, W Jiang, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
December 13, 2023
Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II Trial
E M Cruz-Lim, B Mou, S Baker, et al.
Page
of 3